iRadimed sets the terms for its initial public offering, saying it hopes to raise up to $10.5 million.
iRadimed today set the range for its forthcoming initial public offering at $5 to $6 per share.
Winter Springs, Fla.-based iRadimed said it plans to issue 1.75 million shares in the IPO, making the offering worth between $8.75 million and $10.5 million.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1qVOZ27
Cap comentari:
Publica un comentari a l'entrada